Increased platelet destruction.
D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D001853:Bone Marrow / Q000473:pathology; D002462:Cell Membrane / Q000473:pathology; D002470:Cell Survival; D002860:Chromium Radioisotopes; D003327:Coronary Disease / Q000150:complications; D003937:Diagnosis, Differential; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000175:diagnosis; D005260:Female; D006410:Hematopoiesis; D006801:Humans; D007204:Indium; D007231:Infant, Newborn; D010978:Platelet Factor 4 / Q000032:analysis; D011247:Pregnancy; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011868:Radioisotopes; D018805:Sepsis / Q000150:complications; D013921:Thrombocytopenia / Q000097:blood* / Q000150:complications / Q000276:immunology; D001620:beta-Thromboglobulin / Q000378:metabolism / Q000652:urine
D002860:Chromium Radioisotopes; D011868:Radioisotopes; D001620:beta-Thromboglobulin; D007204:Indium; D010978:Platelet Factor 4; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin